ADA Scientific Sessions 2026 Abstract

Effects of Tirzepatide in Obese Adults with Type 1 Diabetes on Hybrid Closed-Loop Continuous Subcutaneous Insulin Infusion: A 12-Month Observational Study

By Muhammad T. Younas, Polen B. Kahraman, Samina Bibi, Probal K. Moulik

Study in peopleInterventions

The paper

Muhammad T. Younas, Polen B. Kahraman, Samina Bibi, Probal K. Moulik

Shrewsbury

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1705-P

doi.org/10.2337/db26-1705-p

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity